3 Big Cap Biotechs That Could Trounce Gilead Sciences This Year | Traderszone

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 1 March, 2015 by The TZ Newswire Staff

3 Big Cap Biotechs That Could Trounce Gilead Sciences This Year

These three companies could post better growth than Gilead Sciences that allow them to be top performers this year.

See also
- Next Article U.S. Says No Weapons for Ukraine… but Here, Slovakia, Have a Few Helicopters
- Previous Article 26 Unsettling Truths About Social Security
Editorial Calender

March 2015

M T W T F S S

1

2 3 4 5 6 7 8

9 10 11 12 13 14 15

16 17 18 19 20 21 22

23 24 25 26 27 28 29

30 31

« Feb Apr »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar